Accessibility Menu
Kits Eyecare Stock Quote

Kits Eyecare (TSX: KITS)

$14.35
(-4.5%)
-0.68
Price as of March 13, 2026, 4:00 p.m. ET

KEY DATA POINTS

Current Price
CA$14.35
Daily Change
(-4.5%) $0.68
Day's Range
CA$14.27 - CA$15.33
Previous Close
CA$14.35
Open
CA$15.32
Beta
0.61
Volume
134,322
Average Volume
98,489
Market Cap
$463M
Market Cap / Employee
$14.35M
52wk Range
CA$9.10 - CA$22.56
Revenue
N/A
Gross Margin
0.35%
Dividend Yield
N/A
EPS
CA$0.09
CAPs Rating
N/A
Industry
Specialty Retail

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Kits Eyecare Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
KITS+58.56%+62.33%+10.16%+58%
S&P+20.12%+68.19%+10.95%+75%

Kits Eyecare Company Info

Kits Eyecare Ltd. engages in the online retailing of eye care products. It operates through the following geographical segments: United States, Canada, and Rest of the World. The firm offers contact lenses, blue light blocking lenses, accessories, and sunglasses for men and women. The company was founded by Roger Hardy, Sabrina Liak and Joseph Thompson on October 15, 2018 and is headquartered in Vancouver, Canada.

News & Analysis

No results found

No news articles found for Kits Eyecare.

Financial Health

General

Q4 2025YOY Change
Revenue$53.89M20.2%
Gross Profit$18.69M16.5%
Gross Margin34.68%-1.1%
Market Cap$589.14M121.3%
Market Cap / Employee$3.35M0.0%
Employees1768.6%
Net Income$264.00K-90.3%
EBITDA$2.77M-2.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q4 2025YOY Change
Net Cash$29.82M54.7%
Accounts Receivable$2.22M0.9%
Inventory23.75.3%

Liabilities

Q4 2025YOY Change
Long Term Debt$4.72M-26.0%
Short Term Debt$11.10M78.5%

Ratios

Q4 2025YOY Change
Return On Assets2.88%-0.4%
Return On Invested Capital-14.21%0.9%

Cash Flow

Q4 2025YOY Change
Free Cash Flow$6.44M138.6%
Operating Free Cash Flow$6.45M69.9%

Valuation

MetricQ1 2025Q2 2025Q3 2025Q4 2025YoY Change
Price to Earnings82.04127.3992.54188.77121.02%
Price to Book6.587.998.819.5090.35%
Price to Sales2.392.662.873.0970.87%
Price to Tangible Book Value24.4726.1427.4628.0442.73%
Price to Free Cash Flow TTM56.4673.7629.1465.2620.42%
Enterprise Value to EBITDA125.49247.29196.43219.51120.98%
Free Cash Flow Yield1.8%1.4%3.4%1.5%-16.96%
Return on Equity8.2%6.7%9.7%5.2%-9.22%
Total Debt$9.53M$7.72M$7.21M$15.82M25.57%

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.